New cancer clinical trial: Immunopheresis Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Advanced Triple Negative Breast Cancer (TNBC)

Published on: July 02, 2019 at 07:00PM
Condition:   Advanced Triple Negative Breast Cancer
Interventions:   Other: Plasma soluble TNF receptor pulldown;   Other: Plasma soluble TNF receptor pulldown + chemotherapy;   Drug: Chemotherapy Drugs, Cancer
Sponsor:   Immunicom Inc
Recruiting